Viewing nowEntitelmi Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Korea Shionogi Pharmaceutical Co., Ltd.

MFDS item code 201904775 · Approved 2019.07.16 · Insurance code 623005210
Treatment of essential hypertension and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is effective for patients with essential hypertension and is used to reduce the risk of death from myocardial infarction, stroke, or cardiovascular diseases. It especially helps reduce the risk of cardiovascular diseases in high-risk patients aged 55 years and older who cannot use ACE inhibitors. This medication plays an important role in improving cardiovascular health and lowering risk.
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If needed, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to this medication or its components, pregnant women, nursing mothers, those with severe liver impairment, certain hereditary angioedema, and those with diabetes or moderate to severe renal impairment should not take this medication. Elderly patients or those with high serum potassium levels, liver disease, heart disease, gastrointestinal disease, or renal vascular disease should use this medication cautiously, especially in cases of severe renal impairment. Various side effects may occur during treatment with this medication. Common symptoms include headache, dizziness, cough, dyspepsia, and palpitations, while rare but serious allergic reactions or angioedema, and renal function impairment may occur. Any unusual symptoms should prompt immediate consultation with a doctor. Additionally, this medication lowers blood pressure, which may cause hypotension or fainting. If these symptoms are severe, appropriate measures should be taken. When taken in conjunction with other antihypertensive medications, the blood pressure-lowering effect may be enhanced, and concomitant use with specific medications may increase the risk of renal function deterioration or hyperkalemia. Therefore, it is essential to inform the doctor or pharmacist of any other medications being taken. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers should also avoid its use. Safety for children has not been established, so it is recommended that children under 18 years old do not take this medication. In case of overdose, symptoms such as hypotension, changes in heart rate, dizziness, or renal failure may occur, and immediate medical attention should be sought. This medication should be kept out of reach of children, and it is advisable not to transfer it to another container. Finally, caution is advised while driving or operating machinery during treatment as dizziness or fainting may occur.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C.
White oval-shaped tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Korea Shionogi Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.